5,000-Patient study tests jardiance against standard heart failure drugs in china

This study looks at how well the drug Jardiance works compared to other standard heart failure treatments in Chinese patients with a specific type of heart failure (HFrEF). Researchers will track about 5,000 adults to see which treatment better prevents heart failure hospitalizations or death from heart problems. The goal is to provide real-world evidence on Jardiance's effectiveness and safety in this population.